Inflammatory Bowel Disease Biomarkers of Human Gut Microbiota Selected
  via Ensemble Feature Selection Methods
  The tremendous boost in the next generation sequencing and in the omics
technologies makes it possible to characterize human gut microbiome (the
collective genomes of the microbial community that reside in our
gastrointestinal tract). While some of these microorganisms are considered as
essential regulators of our immune system, some others can cause several
diseases such as Inflammatory Bowel Diseases (IBD), diabetes, and cancer. IBD,
is a gut related disorder where the deviations from the healthy gut microbiome
are considered to be associated with IBD. Although existing studies attempt to
unveal the composition of the gut microbiome in relation to IBD diseases, a
comprehensive picture is far from being complete. Due to the complexity of
metagenomic studies, the applications of the state of the art machine learning
techniques became popular to address a wide range of questions in the field of
metagenomic data analysis. In this regard, using IBD associated metagenomics
dataset, this study utilizes both supervised and unsupervised machine learning
algorithms, i) to generate a classification model that aids IBD diagnosis, ii)
to discover IBD associated biomarkers, iii) to find subgroups of IBD patients
using k means and hierarchical clustering. To deal with the high dimensionality
of features, we applied robust feature selection algorithms such as Conditional
Mutual Information Maximization (CMIM), Fast Correlation Based Filter (FCBF),
min redundancy max relevance (mRMR) and Extreme Gradient Boosting (XGBoost). In
our experiments with 10 fold cross validation, XGBoost had a considerable
effect in terms of minimizing the microbiota used for the diagnosis of IBD and
thus reducing the cost and time. We observed that compared to the single
classifiers, ensemble methods such as kNN and logitboost resulted in better
performance measures for the classification of IBD.
